{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:28:32Z","timestamp":1793608112414,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["178210"],"award-info":[{"award-number":["178210"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT 153287"],"award-info":[{"award-number":["PJT 153287"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bbi.2026.106575","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:28:52Z","timestamp":1775150932000},"page":"106575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Human APOB-expressing mice translate molecular phenotypes across the Alzheimer\u2019s disease spectrum"],"prefix":"10.1016","volume":"136","author":[{"given":"Gabriel","family":"Aumont-Rodrigue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8018-4545","authenticated-orcid":false,"given":"Judes","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bbi.2026.106575_b0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1600-0404.2007.00823.x","article-title":"The integrity of the blood-brain barrier in Alzheimer's disease","volume":"115","author":"Algotsson","year":"2007","journal-title":"Acta Neurol. Scand."},{"issue":"11","key":"10.1016\/j.bbi.2026.106575_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100667","article-title":"Apolipoprotein B gene expression and regulation in relation to Alzheimer's disease pathophysiology [Article]","volume":"65","author":"Aumont-Rodrigue","year":"2024","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.bbi.2026.106575_b0015","doi-asserted-by":"crossref","DOI":"10.1093\/bioadv\/vbac016","article-title":"decoupleR: ensemble of computational methods to infer biological activities from omics data [Article]","volume":"2","author":"Badia-i-Mompel","year":"2022","journal-title":"BIOINFORMATICS ADVANCES"},{"issue":"6205","key":"10.1016\/j.bbi.2026.106575_b0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.1252945","article-title":"Aging-induced type I interferon response at the choroid plexus negatively affects brain function [Article]","volume":"346","author":"Baruch","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bbi.2026.106575_b0025","first-page":"159","article-title":"Religious orders Study and Rush memory and Aging Project","volume":"Vol. 6","author":"Bennett","year":"2018"},{"issue":"6","key":"10.1016\/j.bbi.2026.106575_b0030","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1021\/pr7006329","article-title":"Overexpression of human apolipoprotein B-100 induces severe neurodegeneration in transgenic mice","volume":"7","author":"Bereczki","year":"2008","journal-title":"J. Proteome Res."},{"issue":"5262","key":"10.1016\/j.bbi.2026.106575_b0035","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1126\/science.272.5262.685","article-title":"Mouse models of atherosclerosis [Article]","volume":"272","author":"Breslow","year":"1996","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbi.2026.106575_b0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0404.1999.tb00724.x","article-title":"Increased apolipoprotein B serum concentration in Alzheimer's disease","volume":"100","author":"Caramelli","year":"1999","journal-title":"Acta Neurol. Scand."},{"issue":"32","key":"10.1016\/j.bbi.2026.106575_b0045","doi-asserted-by":"crossref","first-page":"23747","DOI":"10.1016\/S0021-9258(20)80442-6","article-title":"Expression of human apolipoprotein B100 in transgenic mice. Editing of human apolipoprotein B100 mRNA","volume":"268","author":"Chiesa","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bbi.2026.106575_b0050","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-Associated Microglia: a Universal Immune Sensor of Neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bbi.2026.106575_b0055","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/ATVBAHA.111.226100","article-title":"Triglycerides and Heart Disease still a Hypothesis? [Review]","volume":"31","author":"Goldberg","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbi.2026.106575_b0060","article-title":"Neuroinflammation in Alzheimer disease [Review; Early Access]","author":"Heneka","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"9046","key":"10.1016\/j.bbi.2026.106575_b0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(96)09328-2","article-title":"Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study","volume":"349","author":"Hofman","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2026.106575_b0070","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fncel.2018.00380","article-title":"Cerebrovascular Pathology in Hypertriglyceridemic APOB-100 Transgenic mice","volume":"12","author":"Hoyk","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2026.106575_b0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1194\/jlr.R200014-JLR200","article-title":"Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly [Review]","volume":"44","author":"Hussain","year":"2003","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.bbi.2026.106575_b0080","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1006\/bbrc.1998.9652","article-title":"Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels","volume":"252","author":"Kuo","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbi.2026.106575_b0085","article-title":"Increased Tau Phosphorylation and Impaired Presynaptic Function in Hypertriglyceridemic ApoB-100 Transgenic mice [Article]","volume":"7(9), 12","author":"Lenart","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2026.106575_b0090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ebiom.2016.06.002","article-title":"ADAM30 Downregulates APP-Linked Defects through Cathepsin D Activation in Alzheimer's Disease [Article]","volume":"9","author":"Letronne","year":"2016","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.bbi.2026.106575_b0095","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1172\/JCI116927","article-title":"Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a)","volume":"92","author":"Linton","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bbi.2026.106575_b0100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/icb.2013.64","article-title":"The adaptor protein Crk in immune response [Review]","volume":"92","author":"Liu","year":"2014","journal-title":"Immunol. Cell Biol."},{"issue":"6","key":"10.1016\/j.bbi.2026.106575_b0105","first-page":"5751","article-title":"Increased expression of Myc-interacting zinc finger protein 1 in APP\/PS1 mice [Article]","volume":"14","author":"Liu","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"10","key":"10.1016\/j.bbi.2026.106575_b0110","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.neurobiolaging.2013.04.008","article-title":"Impact of ApoB-100 expression on cognition and brain pathology in wild-type and hAPPsl mice [Article]","volume":"34","author":"Loffler","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.bbi.2026.106575_b0115","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/2013.jamaneurol.405","article-title":"The aging brain and cognition: contribution of vascular injury and a\u03b2 to mild cognitive dysfunction","volume":"70","author":"Marchant","year":"2013","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.bbi.2026.106575_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101121","article-title":"A protocol to extract cell-type-specific signatures from differentially expressed genes in bulk-tissue RNA-seq [Article]","volume":"3","author":"Marquez-Galera","year":"2022","journal-title":"STAR Protoc."},{"issue":"2","key":"10.1016\/j.bbi.2026.106575_b0125","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0304-3940(92)90531-B","article-title":"Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease","volume":"134","author":"Namba","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2026.106575_b0130","doi-asserted-by":"crossref","unstructured":"Picard, C., Nilsson, N., Labonte, A., Auld, D., Rosa-Neto, P., Alzheimer's Disease Neuroimaging, I.,\u2026group, P.-A. r. (2021). Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.12442.","DOI":"10.1002\/alz.12442"},{"key":"10.1016\/j.bbi.2026.106575_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.36","article-title":"Global quantitative analysis of the human brain proteome in Alzheimer's and Parkinson's Disease [Article; Data Paper]","volume":"5","author":"Ping","year":"2018","journal-title":"Sci. Data"},{"issue":"6","key":"10.1016\/j.bbi.2026.106575_b0140","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0092-8674(87)90510-1","article-title":"A NOVEL FORM OF TISSUE-SPECIFIC RNA PROCESSING PRODUCES APOLIPOPROTEIN-B48 IN INTESTINE [Article]","volume":"50","author":"Powell","year":"1987","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbi.2026.106575_b0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jalz.2017.07.757","article-title":"Association of midlife lipids with 20-year cognitive change: a cohort study","volume":"14","author":"Power","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.bbi.2026.106575_b0150","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000330020","article-title":"Vascular risk factors and dementia: 40-year follow-up of a population-based cohort","volume":"31","author":"R\u00f6nnemaa","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"8","key":"10.1016\/j.bbi.2026.106575_b0155","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14897","article-title":"Mitochondrial plasticity and synaptic plasticity crosstalk; in health and Alzheimer's disease","volume":"30","author":"Sayehmiri","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bbi.2026.106575_b0160","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6766460","article-title":"Identification of two CDK5R1-Related Subtypes and Characterization of Immune Infiltrates in Alzheimer's Disease based on an Integrated Bioinformatics Analysis","volume":"2022","author":"Shao","year":"2022","journal-title":"Comput. Math. Methods Med."},{"issue":"4","key":"10.1016\/j.bbi.2026.106575_b0165","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/1097-0029(20000815)50:4<287::AID-JEMT7>3.0.CO;2-L","article-title":"Link between heart disease, cholesterol, and Alzheimer's disease: a review","volume":"50","author":"Sparks","year":"2000","journal-title":"Microsc. Res. Tech."},{"issue":"1","key":"10.1016\/j.bbi.2026.106575_b0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JAD-220399","article-title":"Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-based Approach [Article]","volume":"89","author":"Timsina","year":"2022","journal-title":"JOURNAL OF ALZHEIMERS DISEASE"},{"issue":"13","key":"10.1016\/j.bbi.2026.106575_b0175","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2174\/1381612826666200218101818","article-title":"Cerebrovascular changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic mice [Review]","volume":"26","author":"Toth","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.bbi.2026.106575_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-4827(03)00313-6","article-title":"Regulation of human apolipoprotein B gene expression at multiple levels [Review]","volume":"290","author":"Wang","year":"2003","journal-title":"Exp. Cell Res."},{"issue":"7","key":"10.1016\/j.bbi.2026.106575_b0185","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/jamaneurol.2019.0648","volume":"76","author":"Wingo","year":"2019","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.bbi.2026.106575_b0190","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/01.CIR.82.5.1574","article-title":"RECENT PROGRESS IN UNDERSTANDING APOLIPOPROTEIN-B [Review]","volume":"82","author":"Young","year":"1990","journal-title":"Circulation"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126003235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126003235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:53:29Z","timestamp":1793606009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159126003235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":38,"alternative-id":["S0889159126003235"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106575","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human APOB-expressing mice translate molecular phenotypes across the Alzheimer\u2019s disease spectrum","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106575"}}